Considerations For An Immunogenicity Program Webinar

This webinar first describes how to differentiate the risk associated with internal attributes of the drug from the risk derived from external factors. The second section provides a guideline for selecting the best methods to analyze and characterize antibodies.

Click here to view the webinar